Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SOTI/TROPOS open-label extension of strontium ranelate
ISRCTN48348637Phase 3Completed
- Sponsor
- Servier
- Start
- Sep 2002
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of strontium ranelate in postmenopausal osteoporosis, sponsored by Servier. Primary endpoints: Bone mineral density by DXA, Vertebral fractures on radiographs and 1 more. Started Sep 2002; status: completed.
02
Drugs
strontium ranelate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on ISRCTN48348637.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48348637.